Literature DB >> 19342051

Revised FIGO staging for carcinoma of the cervix.

Sergio Pecorelli1, Lucia Zigliani, Franco Odicino.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19342051     DOI： 10.1016/j.ijgo.2009.02.009

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  170 in total

1.  Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.

Authors:  Wei Yang; Jin Wei Qiang; Hai Ping Tian; Bing Chen; Ai Jun Wang; Jian Guo Zhao
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer.

Authors:  Shan Chen; Xiao Li; Junpu Qin; Yuan Chen; Longyang Liu; Dongqing Zhang; Minyi Wang; Maocai Wang; Dikai Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro.

Authors:  Liancheng Zhu; Salvatore Lopez; Stefania Bellone; Jonathan Black; Emiliano Cocco; Tiffany Zigras; Federica Predolini; Elena Bonazzoli; Beatrice Bussi; Zachary Stuhmer; Carlton L Schwab; Diana P English; Elena Ratner; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Alessandro D Santin
Journal:  Tumour Biol       Date:  2015-02-11

4.  International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer?

Authors:  Hee Seung Kim; Yong Sang Song
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

5.  Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.

Authors:  Eva Johanna Kantelhardt; Ulrike Moelle; Matthias Begoihn; Adamu Addissie; Pietro Trocchi; Bekuretsion Yonas; Petros Hezkiel; Andreas Stang; Christoph Thomssen; Dirk Vordermark; Tufa Gemechu; Yirgu Gebrehiwot; Tigeneh Wondemagegnehu; Abreha Aynalem; Assefa Mathewos
Journal:  Oncologist       Date:  2014-06-20

6.  Evidence based radiation oncology with existing technology.

Authors:  Nicolas Isa
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-14

7.  Role of computed tomography (CT) scan in staging of cervical carcinoma.

Authors:  T V Prasad; S Thulkar; S Hari; D N Sharma; S Kumar
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

8.  The twenty-first century role of Piver-Rutledge type III radical hysterectomy and FIGO stage IA, IB1, and IB2 cervical cancer in the era of robotic surgery: a personal perspective.

Authors:  M Steven Piver; Ali Ghomi
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

9.  Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.

Authors:  Shuang Li; Ting Hu; Weiguo Lv; Hang Zhou; Xiong Li; Ru Yang; Yao Jia; Kecheng Huang; Zhilan Chen; Shaoshuai Wang; Fangxu Tang; Qinghua Zhang; Jian Shen; Jin Zhou; Ling Xi; Dongrui Deng; Hui Wang; Shixuan Wang; Xing Xie; Ding Ma
Journal:  Oncologist       Date:  2013-09-16

Review 10.  Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis.

Authors:  Maarten G Thomeer; Cees Gerestein; Sandra Spronk; Helena C van Doorn; Els van der Ham; Myriam G Hunink
Journal:  Eur Radiol       Date:  2013-03-01       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.